News | November 24, 2021
Ipca Laboratories acquires 26 % stake in Lyka Labs, makes open offer
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
For the six months ended September 30, 2021, Lyka had reported revenues of Rs 109.87 crore
Suchirayu owns a state-of-the-art multi-speciality hospital in Hubli with an operational capacity of 110 beds and a potential to scale up to 250 beds
ImmunoACT has a portfolio of CAR-T therapy assets under various development stages for the treatment of multiple autoimmune diseases and oncology indications.
Flipkart also announced its foray into the healthcare sector through the launch of Flipkart Health+
The company has operations in North America, Asia, and Europe,
Gini Health works in the domain of personalised healthcare
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
The addition of Abexxa’s expertise complements Boehringer Ingelheim’s current approaches to the treatment of difficult-to-treat solid cancers and especially those resistant to available immunotherapies
The investment will be used to develop affordable Point of Care labs with 70+ tests. Mylab will start deploying systems with its lab partners from Nov 2021
Subscribe To Our Newsletter & Stay Updated
